{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T13:41:08Z","timestamp":1791380468203,"version":"4.3.3"},"reference-count":73,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JASN"],"published-print":{"date-parts":[[2016,12]]},"abstract":"<jats:p>\n                    Patients with autosomal dominant polycystic kidney disease (ADPKD) typically carry a mutation in either the\n                    <jats:italic toggle=\"yes\">PKD1<\/jats:italic>\n                    or\n                    <jats:italic toggle=\"yes\">PKD2<\/jats:italic>\n                    gene, which leads to massive cyst formation in both kidneys. However, the large intrafamilial variation in the progression rate of ADPKD suggests involvement of additional factors other than the type of mutation. The identification of these factors will increase our understanding of ADPKD and could ultimately help in the development of a clinically relevant therapy. Our review addresses the mechanisms by which various biologic processes influence cyst formation and cyst growth, thereby explaining an important part of the inter- and intrafamilial variability in ADPKD. Numerous studies from many laboratories provide compelling evidence for the influence on cyst formation by spatiotemporal gene inactivation, the genetic context, the metabolic status, the presence of existing cysts, and whether the kidneys were challenged by renal injury. Collectively, a solid basis is provided for the concept that the probability of cyst formation is determined by functional PKD protein levels and the biologic context. We model these findings in a graphic representation called the cystic probability landscape, providing a robust conceptual understanding of why cells sometimes do or do not form cysts.\n                  <\/jats:p>","DOI":"10.1681\/asn.2016040425","type":"journal-article","created":{"date-parts":[[2016,8,4]],"date-time":"2016-08-04T22:03:57Z","timestamp":1470348237000},"page":"3530-3538","source":"Crossref","is-referenced-by-count":48,"title":["Variable Cyst Development in Autosomal Dominant Polycystic Kidney Disease: The Biologic Context"],"prefix":"10.1681","volume":"27","author":[{"given":"Wouter N.","family":"Leonhard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hester","family":"Happe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorien J.M.","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2016,8,4]]},"reference":[{"key":"B2-20231016","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/0092-8674(94)90137-6","article-title":"The polycystic kidney disease 1 gene encodes a 14 kb transcript and lies within a duplicated region on chromosome 16.","volume":"77","year":"1994","journal-title":"Cell"},{"key":"B3-20231016","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1126\/science.272.5266.1339","article-title":"PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein.","volume":"272","author":"Mochizuki","year":"1996","journal-title":"Science"},{"key":"B4-20231016","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1681\/ASN.2012070650","article-title":"Type of PKD1 mutation influences renal outcome in ADPKD.","volume":"24","author":"Cornec-Le Gall","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"B5-20231016","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0272-6386(12)80051-5","article-title":"Autosomal dominant polycystic kidney disease--more than a renal disease.","volume":"16","author":"Gabow","year":"1990","journal-title":"Am J Kidney Dis"},{"key":"B6-20231016","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/S0092-8674(00)81793-6","article-title":"The molecular basis of focal cyst formation in human autosomal dominant polycystic kidney disease type I.","volume":"87","author":"Qian","year":"1996","journal-title":"Cell"},{"key":"B7-20231016","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1681\/ASN.V1071524","article-title":"Somatic PKD2 mutations in individual kidney and liver cysts support a \u201ctwo-hit\u201d model of cystogenesis in type 2 autosomal dominant polycystic kidney disease.","volume":"10","author":"Pei","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"B8-20231016","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/ng1097-179","article-title":"Perinatal lethality with kidney and pancreas defects in mice with a targetted Pkd1 mutation.","volume":"17","author":"Lu","year":"1997","journal-title":"Nat Genet"},{"key":"B9-20231016","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1681\/ASN.2006010052","article-title":"PKD1 haploinsufficiency causes a syndrome of inappropriate antidiuresis in mice.","volume":"18","author":"Ahrabi","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"B10-20231016","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1681\/ASN.2008040435","article-title":"Pkd1 haploinsufficiency increases renal damage and induces microcyst formation following ischemia\/reperfusion.","volume":"20","author":"Bastos","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"B11-20231016","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.2353\/ajpath.2009.090227","article-title":"Pkd2 dosage influences cellular repair responses following ischemia-reperfusion injury.","volume":"175","author":"Prasad","year":"2009","journal-title":"Am J Pathol"},{"key":"B12-20231016","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1093\/hmg\/ddh336","article-title":"Lowering of Pkd1 expression is sufficient to cause polycystic kidney disease.","volume":"13","author":"Lantinga-van Leeuwen","year":"2004","journal-title":"Hum Mol Genet"},{"key":"B13-20231016","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2353\/ajpath.2006.050342","article-title":"Defining a link with autosomal-dominant polycystic kidney disease in mice with congenitally low expression of Pkd1.","volume":"168","author":"Jiang","year":"2006","journal-title":"Am J Pathol"},{"key":"B14-20231016","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1161\/ATVBAHA.107.149252","article-title":"Pathogenic sequence for dissecting aneurysm formation in a hypomorphic polycystic kidney disease 1 mouse model.","volume":"27","author":"Hassane","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B15-20231016","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/ng812","article-title":"Efficient generation and mapping of recessive developmental mutations using ENU mutagenesis.","volume":"30","author":"Herron","year":"2002","journal-title":"Nat Genet"},{"key":"B16-20231016","doi-asserted-by":"crossref","first-page":"18688","DOI":"10.1073\/pnas.0708217104","article-title":"Essential role of cleavage of Polycystin-1 at G protein-coupled receptor proteolytic site for kidney tubular structure.","volume":"104","author":"Yu","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B17-20231016","doi-asserted-by":"crossref","first-page":"4257","DOI":"10.1172\/JCI64313","article-title":"Functional polycystin-1 dosage governs autosomal dominant polycystic kidney disease severity.","volume":"122","author":"Hopp","year":"2012","journal-title":"J Clin Invest"},{"key":"B18-20231016","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/ng.860","article-title":"A genetic interaction network of five genes for human polycystic kidney and liver diseases defines polycystin-1 as the central determinant of cyst formation.","volume":"43","author":"Fedeles","year":"2011","journal-title":"Nat Genet"},{"key":"B19-20231016","doi-asserted-by":"crossref","first-page":"3188","DOI":"10.1093\/hmg\/ddm299","article-title":"Kidney-specific inactivation of the Pkd1 gene induces rapid cyst formation in developing kidneys and a slow onset of disease in adult mice.","volume":"16","author":"Lantinga-van Leeuwen","year":"2007","journal-title":"Hum Mol Genet"},{"key":"B20-20231016","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1681\/ASN.2013080864","article-title":"Scattered deletion of PKD1 in kidneys causes a cystic snowball effect and recapitulates polycystic kidney disease.","volume":"26","author":"Leonhard","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"B21-20231016","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1093\/hmg\/9.18.2617","article-title":"A human PKD1 transgene generates functional polycystin-1 in mice and is associated with a cystic phenotype.","volume":"9","author":"Pritchard","year":"2000","journal-title":"Hum Mol Genet"},{"key":"B22-20231016","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1128\/MCB.26.4.1538-1548.2006","article-title":"Overexpression of PKD1 causes polycystic kidney disease.","volume":"26","author":"Thivierge","year":"2006","journal-title":"Mol Cell Biol"},{"key":"B23-20231016","doi-asserted-by":"crossref","first-page":"29577","DOI":"10.1074\/jbc.M203570200","article-title":"The polycystic kidney disease-1 promoter is a target of the beta-catenin\/T-cell factor pathway.","volume":"277","author":"Rodova","year":"2002","journal-title":"J Biol Chem"},{"key":"B24-20231016","doi-asserted-by":"crossref","first-page":"F1845","DOI":"10.1152\/ajprenal.90355.2008","article-title":"Retinoic acid-dependent activation of the polycystic kidney disease-1 (PKD1) promoter.","volume":"295","author":"Islam","year":"2008","journal-title":"Am J Physiol Renal Physiol"},{"key":"B25-20231016","doi-asserted-by":"crossref","first-page":"38818","DOI":"10.1074\/jbc.M110.145284","article-title":"MAP\/ERK kinase 1 (MEKK1) mediates transcriptional repression by interacting with polycystic kidney disease-1 (PKD1) promoter-bound p53 tumor suppressor protein.","volume":"285","author":"Islam","year":"2010","journal-title":"J Biol Chem"},{"key":"B26-20231016","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/sj.ejhg.5201392","article-title":"Common regulatory elements in the polycystic kidney disease 1 and 2 promoter regions.","volume":"13","author":"Lantinga-van Leeuwen","year":"2005","journal-title":"Eur J Hum Genet"},{"issue":"6 Pt B","key":"B27-20231016","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.ygeno.2014.08.006","article-title":"Characterization of the polycystic kidney disease 2 gene promoter.","volume":"104","author":"Wang","year":"2014","journal-title":"Genomics"},{"key":"B28-20231016","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/71724","article-title":"Cardiac defects and renal failure in mice with targeted mutations in Pkd2.","volume":"24","author":"Wu","year":"2000","journal-title":"Nat Genet"},{"key":"B29-20231016","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/nrneph.2014.137","article-title":"Translational research in ADPKD: Lessons from animal models.","volume":"10","author":"Happ\u00e9","year":"2014","journal-title":"Nat Rev Nephrol"},{"key":"B30-20231016","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1038\/nm1675","article-title":"A critical developmental switch defines the kinetics of kidney cyst formation after loss of Pkd1.","volume":"13","author":"Piontek","year":"2007","journal-title":"Nat Med"},{"key":"B31-20231016","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1016\/j.juro.2012.12.002","article-title":"Comprehensive gene expression changes associated with mouse postnatal kidney development.","volume":"189","author":"Wu","year":"2013","journal-title":"J Urol"},{"key":"B32-20231016","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1093\/hmg\/ddp190","article-title":"Toxic tubular injury in kidneys from Pkd1-deletion mice accelerates cystogenesis accompanied by dysregulated planar cell polarity and canonical Wnt signaling pathways.","volume":"18","author":"Happ\u00e9","year":"2009","journal-title":"Hum Mol Genet"},{"key":"B33-20231016","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1038\/ki.2013.13","article-title":"Cyst expansion and regression in a mouse model of polycystic kidney disease.","volume":"83","author":"Happ\u00e9","year":"2013","journal-title":"Kidney Int"},{"key":"B34-20231016","doi-asserted-by":"crossref","first-page":"889","DOI":"10.2215\/CJN.00550110","article-title":"Evidence of extraordinary growth in the progressive enlargement of renal cysts.","volume":"5","author":"Grantham","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"B35-20231016","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/ki.2008.686","article-title":"Incompletely penetrant PKD1 alleles suggest a role for gene dosage in cyst initiation in polycystic kidney disease.","volume":"75","author":"Rossetti","year":"2009","journal-title":"Kidney Int"},{"key":"B36-20231016","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1681\/ASN.2009101070","article-title":"Incompletely penetrant PKD1 alleles mimic the renal manifestations of ARPKD.","volume":"21","author":"Vujic","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"B37-20231016","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1136\/jmedgenet-2011-100452","article-title":"Neonatal onset autosomal dominant polycystic kidney disease (ADPKD) in a patient homozygous for a PKD2 missense mutation due to uniparental disomy.","volume":"49","author":"Losekoot","year":"2012","journal-title":"J Med Genet"},{"key":"B38-20231016","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.2215\/CJN.00900112","article-title":"Detected renal cysts are tips of the iceberg in adults with ADPKD.","volume":"7","author":"Grantham","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"B39-20231016","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/5007","article-title":"Generalized lacZ expression with the ROSA26 Cre reporter strain.","volume":"21","author":"Soriano","year":"1999","journal-title":"Nat Genet"},{"key":"B40-20231016","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1093\/hmg\/ddn045","article-title":"Acute kidney injury and aberrant planar cell polarity induce cyst formation in mice lacking renal cilia.","volume":"17","author":"Patel","year":"2008","journal-title":"Hum Mol Genet"},{"key":"B41-20231016","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1093\/hmg\/ddp147","article-title":"Renal injury is a third hit promoting rapid development of adult polycystic kidney disease.","volume":"18","author":"Takakura","year":"2009","journal-title":"Hum Mol Genet"},{"key":"B42-20231016","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1681\/ASN.2010050526","article-title":"Loss of primary cilia upregulates renal hypertrophic signaling and promotes cystogenesis.","volume":"22","author":"Bell","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"B43-20231016","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1681\/ASN.2012020154","article-title":"Proximal tubule proliferation is insufficient to induce rapid cyst formation after cilia disruption.","volume":"24","author":"Sharma","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"B44-20231016","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1038\/ki.1987.121","article-title":"Cyst formation and growth in autosomal dominant polycystic kidney disease.","volume":"31","author":"Grantham","year":"1987","journal-title":"Kidney Int"},{"key":"B45-20231016","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1016\/j.ajpath.2014.03.007","article-title":"Tubular obstruction leads to progressive proximal tubular injury and atubular glomeruli in polycystic kidney disease.","volume":"184","author":"Galarreta","year":"2014","journal-title":"Am J Pathol"},{"key":"B46-20231016","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1681\/ASN.2011010084","article-title":"Macrophages promote cyst growth in polycystic kidney disease.","volume":"22","author":"Karihaloo","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"B47-20231016","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1159\/000364945","article-title":"M1 and M2 macrophages: The chicken and the egg of immunity.","volume":"6","author":"Mills","year":"2014","journal-title":"J Innate Immun"},{"key":"B48-20231016","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/ki.2012.446","article-title":"Macrophages promote polycystic kidney disease progression.","volume":"83","author":"Swenson-Fields","year":"2013","journal-title":"Kidney Int"},{"key":"B49-20231016","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1681\/ASN.2010030237","article-title":"Genetic variation of DKK3 may modify renal disease severity in ADPKD.","volume":"21","author":"Liu","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"B50-20231016","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1086\/302044","article-title":"Do human chromosomal bands 16p13 and 22q11-13 share ancestral origins?","volume":"63","author":"Giles","year":"1998","journal-title":"Am J Hum Genet"},{"key":"B51-20231016","first-page":"529","article-title":"Autosomal dominant polycystic kidney disease coexisting with cystic fibrosis.","volume":"19","author":"Xu","year":"2006","journal-title":"J Nephrol"},{"key":"B52-20231016","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1681\/ASN.V661643","article-title":"More adverse renal prognosis of autosomal dominant polycystic kidney disease in families with primary hypertension.","volume":"6","author":"Geberth","year":"1995","journal-title":"J Am Soc Nephrol"},{"key":"B53-20231016","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1681\/ASN.2010101080","article-title":"Mutations in multiple PKD genes may explain early and severe polycystic kidney disease.","volume":"22","author":"Bergmann","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"B54-20231016","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ebiom.2016.01.027","article-title":"Fatty acid oxidation is impaired in an orthologous mouse model of autosomal dominant polycystic kidney disease.","volume":"5","author":"Menezes","year":"2016","journal-title":"EBioMedicine"},{"key":"B55-20231016","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/nm.3092","article-title":"Defective glucose metabolism in polycystic kidney disease identifies a new therapeutic strategy.","volume":"19","author":"Rowe","year":"2013","journal-title":"Nat Med"},{"key":"B56-20231016","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1681\/ASN.2015030231","article-title":"2-Deoxy-d-glucose ameliorates PKD progression.","volume":"27","author":"Chiaravalli","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"B58-20231016","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1681\/ASN.2015020132","article-title":"Food restriction ameliorates the development of polycystic kidney disease.","volume":"27","author":"Warner","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"B59-20231016","article-title":"Diet and polycystic kidney disease: A pilot intervention study [published online ahead of print January 11, 2016].","author":"Taylor","journal-title":"Clin Nutr"},{"key":"B60-20231016","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1056\/NEJMoa1205511","article-title":"Tolvaptan in patients with autosomal dominant polycystic kidney disease.","volume":"367","author":"Torres","year":"2012","journal-title":"N Engl J Med"},{"key":"B61-20231016","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1172\/JCI72272","article-title":"Genetic mechanisms and signaling pathways in autosomal dominant polycystic kidney disease.","volume":"124","author":"Harris","year":"2014","journal-title":"J Clin Invest"},{"key":"B62-20231016","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1053\/j.ajkd.2013.10.011","article-title":"Rationale and design of the DIPAK 1 study: A randomized controlled clinical trial assessing the efficacy of lanreotide to Halt disease progression in autosomal dominant polycystic kidney disease.","volume":"63","author":"Meijer","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"B63-20231016","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1681\/ASN.2007060665","article-title":"Src inhibition ameliorates polycystic kidney disease.","volume":"19","author":"Sweeney","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"B64-20231016","doi-asserted-by":"crossref","first-page":"F1193","DOI":"10.1152\/ajprenal.00419.2010","article-title":"Curcumin inhibits cystogenesis by simultaneous interference of multiple signaling pathways: In vivo evidence from a Pkd1-deletion model.","volume":"300","author":"Leonhard","year":"2011","journal-title":"Am J Physiol Renal Physiol"},{"key":"B65-20231016","doi-asserted-by":"crossref","first-page":"7985","DOI":"10.1073\/pnas.1103816108","article-title":"Polycystin-1 regulates STAT activity by a dual mechanism.","volume":"108","author":"Talbot","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B66-20231016","article-title":"Inhibition of activin signaling slows progression of polycystic kidney disease [published online ahead of print March 28, 2016].","author":"Leonhard","journal-title":"J Am Soc Nephrol"},{"key":"B67-20231016","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1073\/pnas.1011498108","article-title":"Activating AMP-activated protein kinase (AMPK) slows renal cystogenesis.","volume":"108","author":"Takiar","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B68-20231016","doi-asserted-by":"crossref","first-page":"4389","DOI":"10.1073\/pnas.0700499104","article-title":"Triptolide is a traditional Chinese medicine-derived inhibitor of polycystic kidney disease.","volume":"104","author":"Leuenroth","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B69-20231016","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1681\/ASN.2011040340","article-title":"Dose-dependent effects of sirolimus on mTOR signaling and polycystic kidney disease.","volume":"23","author":"Novalic","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"B70-20231016","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1681\/ASN.2012040367","article-title":"Folate-conjugated rapamycin slows progression of polycystic kidney disease.","volume":"23","author":"Shillingford","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"B71-20231016","doi-asserted-by":"crossref","first-page":"4919","DOI":"10.1093\/hmg\/ddu208","article-title":"An mTOR anti-sense oligonucleotide decreases polycystic kidney disease in mice with a targeted mutation in Pkd2.","volume":"23","author":"Ravichandran","year":"2014","journal-title":"Hum Mol Genet"},{"key":"B72-20231016","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/ndt\/gfu296","article-title":"An mTOR kinase inhibitor slows disease progression in a rat model of polycystic kidney disease.","volume":"30","author":"Ravichandran","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"B73-20231016","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1172\/JCI64401","article-title":"Sirtuin 1 inhibition delays cyst formation in autosomal-dominant polycystic kidney disease.","volume":"123","author":"Zhou","year":"2013","journal-title":"J Clin Invest"},{"key":"B74-20231016","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1053\/j.gastro.2009.07.052","article-title":"Lanreotide reduces the volume of polycystic liver: A randomized, double-blind, placebo-controlled trial.","volume":"137","author":"van Keimpema","year":"2009","journal-title":"Gastroenterology"},{"key":"B75-20231016","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/path.2734","article-title":"Elevated TGFbeta-Smad signalling in experimental Pkd1 models and human patients with polycystic kidney disease.","volume":"222","author":"Hassane","year":"2010","journal-title":"J Pathol"}],"container-title":["Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00001751-201612000-00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T19:32:05Z","timestamp":1786131125000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001751-201612000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,4]]},"references-count":73,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1681\/asn.2016040425","relation":{},"ISSN":["1046-6673","1533-3450"],"issn-type":[{"value":"1046-6673","type":"print"},{"value":"1533-3450","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,4]]}}}